SOPHiA GENETICS (NASDAQ:SOPH) vs. Information Analysis (OTCMKTS:IAIC) Head-To-Head Survey

Information Analysis (OTCMKTS:IAIC) and SOPHiA GENETICS (NASDAQ:SOPH) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings.

Valuation & Earnings

This table compares Information Analysis and SOPHiA GENETICS”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Information Analysis	$13.90 million	0.00	$410,000.00	$0.04	N/A
SOPHiA GENETICS	$77.27 million	9.39	-$79.00 million	($1.15)	-7.52

Information Analysis has higher earnings, but lower revenue than SOPHiA GENETICS. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than Information Analysis, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Information Analysis has a beta of 3.25, suggesting that its share price is 225% more volatile than the S&P 500. Comparatively, SOPHiA GENETICS has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.

Institutional and Insider Ownership

31.6% of SOPHiA GENETICS shares are owned by institutional investors. 23.8% of Information Analysis shares are owned by insiders. Comparatively, 4.9% of SOPHiA GENETICS shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Information Analysis and SOPHiA GENETICS, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Information Analysis	0	0	0	0	0.00
SOPHiA GENETICS	1	1	3	0	2.40

SOPHiA GENETICS has a consensus target price of $10.00, indicating a potential upside of 15.61%. Given SOPHiA GENETICS’s stronger consensus rating and higher probable upside, analysts clearly believe SOPHiA GENETICS is more favorable than Information Analysis.

Profitability

This table compares Information Analysis and SOPHiA GENETICS’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Information Analysis	3.72%	18.48%	9.33%
SOPHiA GENETICS	-93.86%	-132.47%	-45.97%

Summary

Information Analysis beats SOPHiA GENETICS on 8 of the 13 factors compared between the two stocks.

About Information Analysis

Information Analysis, Inc. provides information technology services. The firm engages in the business of modernizing client information systems, developing and maintaining information technology systems, and performing consulting services to government and commercial organizations. It specializes in legacy systems modernization, ebusiness solutions, enterprise portals, system migration and re-hosting services, and enterprise application integration. The company was founded by Sandor Rosenberg in 1979 and is headquartered in Fairfax, VA.

About SOPHiA GENETICS

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.